HRMY logo

HRMY

Profile

Full Name

Harmony Biosciences Holdings, Inc.

Ticker Symbol

HRMY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 19, 2020

Indexes

Not included

Website

http://www.harmonybiosciences.com

Employees

268

Key Details

Price

$28.46(+1.86%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$714.73M(+22.80% YoY)

Annual EPS

$2.51(+17.84% YoY)

PE ratio

11.34

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$28.46
HRMY price is $28.46

30-Day Relative Volume

0.55
HRMY 30-day relative volume is 0.55

Price Performance

Price Most recent change

+1.86%
HRMY price was up +1.86% on Apr 17, 2025

Price YTD change

-17.29%
HRMY price is down -17.29% since January 1st

Price 1-year change

-2.5%
HRMY price is down -2.5% year-on-year

Price 3-year change

-44.78%
HRMY price is down -44.78% over the past 3 years

Price Range

Price All-time high

$62.09
HRMY price is currently -54.16% below its historical high of $62.09

Price 3-year low

$18.61
HRMY price is currently +52.92% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.63B
HRMY market capitalization is $1.63 billion

Market cap 3-year change

-46.36%
HRMY market capitalization is down -46.36% over the past 3 years

Market cap All-time high

$3.62B
HRMY market capitalization is currently -54.90% below its historical high of $3.62 billion

Market cap sector rank

81.4%
HRMY market capitalization is higher than 81.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.98%
HRMY shares outstanding is up +0.98% year-on-year

Shares Outstanding 3-Year Change

-2.85%
HRMY shares outstanding is down -2.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.63
HRMY beta is 0.63

200-day SMA

$34.76
HRMY price is currently -18.11% below its 200-day simple moving average

50-day SMA

$33.47
HRMY price is currently -14.97% below its 50-day simple moving average

RSI

33.78
HRMY 14-day relative strength index is 33.78

Volume

0.55
HRMY 30-day relative volume is 0.55

ATR

$1.45
HRMY average true range is $1.45

10-day Historical Volatility

42.65%
HRMY 10-day historical volatility is 42.65%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$714.73M
HRMY annual revenue is $714.73 million

Revenue Analysts estimate

$842.11M
HRMY annual revenue is currently -15.13% lower than the consensus analysts' forecast

Revenue 1-year change

+22.8%
HRMY annual revenue is up +22.8% year-on-year

Revenue Sector rank

77.8%
HRMY annual revenue is higher than 77.8% of companies in Healthcare sector

EPS

EPS

$2.51
HRMY annual earnings per share is $2.51

EPS Analysts estimate

$4.52
HRMY annual earnings per share is currently -44.47% lower than the consensus analysts' forecast

EPS 1-year change

+17.84%
HRMY annual earnings per share is up +17.84% year-on-year

EPS Sector rank

93.29%
HRMY annual earnings per share is higher than 93.29% of companies in Healthcare sector

Profit

Gross profit

$557.92M
HRMY annual gross profit is $557.92 million

Gross margin

78.06%
HRMY annual gross profit margin is 78.06%

Operating profit

$190.83M
HRMY annual operating income is $190.83 million

Operating margin

26.70%
HRMY annual operating profit margin is 26.70%

Net income

$145.49M
HRMY annual net profit is $145.49 million

Net margin

20.36%
HRMY annual net profit margin is 20.36%

Expenses

Total expenses

$523.91M
HRMY annual total expenses is $523.91 million

Operating expenses

$367.09M
HRMY annual total operating expenses is $367.09 million

Cost of goods sold

$156.81M
HRMY annual cost of goods sold is $156.81 million

Selling, general & administrative expenses

$221.27M
HRMY annual SGA is $221.27 million

Depreciation and amortization

$24.11M
HRMY annual depreciation & amortization is $24.11 million

Interest expense

$17.50M
HRMY annual interest expense is $17.50 million

Income tax

$46.31M
HRMY annual income tax is $46.31 million

EBIT & EBITDA

EBIT

$209.30M
HRMY annual earnings before interest & taxes is $209.30 million

EBITDA

$233.41M
HRMY annual EBITDA is $233.41 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$999.20M
HRMY annual total assets is $999.20 million

Non current assets

$419.95M
HRMY annual long term assets is $419.95 million

Current assets

$579.25M
HRMY annual total current assets is $579.25 million

Cash and cash equivalents

$453.00M
HRMY annual cash & cash equivalents is $453.00 million

Accounts receivable

$83.03M
HRMY annual accounts receivable is $83.03 million

Inventory

$7.20M
HRMY annual inventory is $7.20 million

Liabilities

Total liabilities

$340.05M
HRMY annual total liabilities is $340.05 million

Long term liabilities

$164.96M
HRMY annual total long term liabilities is $164.96 million

Current liabilities

$175.08M
HRMY annual total current liabilities is $175.08 million

Accounts payable

$13.74M
HRMY annual accounts payable is $13.74 million

Debt

Total debt

$179.27M
HRMY annual total debt is $179.27 million

Total debt 1-year change

-7.39%
HRMY annual total debt is down -7.39% year-on-year

Long term debt

$163.02M
HRMY annual long term debt is $163.02 million

Short term debt

$16.25M
HRMY annual short term debt is $16.25 million

Equity & Capital

Shareholders equity

$659.15M
HRMY annual stockholders equity is $659.15 million

Book value

$659.15M
HRMY annual book value is $659.15 million

Retained earnings

$2.22M
HRMY annual retained earnings is $2.22 million

Working capital

$404.17M
HRMY annual working capital is $404.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$219.82M
HRMY annual cash flow from operations is $219.82 million

Cash from operations 1-year change

+0.2%
HRMY annual cash flow from operations is up +0.2% year-on-year

Cash from investing

-$67.48M
HRMY annual cash flow from investing activities is -$67.48 million

Cash from investing 1-year change

-45.32%
HRMY annual cash flow from investing activities is down -45.32% year-on-year

Cash from financing

-$11.00M
HRMY annual cash flow from financing activities is -$11.00 million

Cash from financing 1-year change

+89.58%
HRMY annual cash flow from financing activities is up +89.58% year-on-year

CAPEX

CAPEX

$1.15M
HRMY annual capital expenditures is $1.15 million

CAPEX 1-year change

+269.55%
HRMY annual capital expenditures is up +269.55% year-on-year

Free Cash Flow

Free cash flow

$218.67M
HRMY annual free cash flow is $218.67 million

Free cash flow 1-year change

-0.19%
HRMY annual free cash flow is down -0.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

78.06%
HRMY annual gross profit margin is 78.06%

Operating margin

26.70%
HRMY annual operating profit margin is 26.70%

Net margin

20.36%
HRMY annual net profit margin is 20.36%

ROA & ROE

ROA

16.07%
HRMY annual return on assets is 16.07%

ROE

25.84%
HRMY annual return on equity is 25.84%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

11.34
HRMY price to earnings ratio is 11.34

PE ratio Sector rank

17.65%
HRMY price to earnings ratio is higher than 17.65% of companies in Healthcare sector

PB Ratio

PB ratio

2.48
HRMY price to book ratio is 2.48

PB ratio Sector rank

68.18%
HRMY price to book ratio is higher than 68.18% of companies in Healthcare sector

PS Ratio

PS ratio

2.28
HRMY price to sales ratio is 2.28

PS ratio Sector rank

45.7%
HRMY price to sales ratio is higher than 45.7% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.36B
HRMY enterprise value is $1.36 billion

Enterprise value Sector rank

78.02%
HRMY enterprise value is higher than 78.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

5.82
HRMY EV/EBITDA is 5.82

EV/EBITDA Sector rank

78.85%
HRMY EV/EBITDA is higher than 78.85% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.31
HRMY annual current ratio is 3.31

Quick ratio

3.27
HRMY annual quick ratio is 3.27

Leverage

Debt to equity

0.27
HRMY annual debt to equity ratio is 0.27

Interest coverage ratio

11.96
HRMY annual interest coverage ratio is 11.96

Risk & Stability

Piotroski F-Score

7
HRMY piotroski f-score is 7

Altman Z-Score

4.77
HRMY altman z-score is 4.77

Analyst ratings

Recent major analysts updates

Apr 10, 25 Needham
Buy
Apr 8, 25 Needham
Buy
Apr 8, 25 HC Wainwright & Co.
Buy
Mar 18, 25 Mizuho
Outperform
Feb 27, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Needham
Buy
Feb 25, 25 Needham
Buy
Feb 20, 25 Mizuho
Outperform
Feb 19, 25 Needham
Buy
Feb 19, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Ascentage Pharma Group International (AAPG)
CNTA logo
Centessa Pharmaceuticals (CNTA)
GLPG logo
Galapagos NV (GLPG)
UFPT logo
UFP Technologies (UFPT)
AGL logo
agilon health (AGL)
AGIO logo
Agios Pharmaceuticals (AGIO)
KYMR logo
Kymera Therapeutics (KYMR)
CGON logo
CG Oncology (CGON)
QDEL logo
QuidelOrtho (QDEL)
  • What is the ticker symbol for Harmony Biosciences Holdings?
  • Does Harmony Biosciences Holdings pay dividends?
  • What sector is Harmony Biosciences Holdings in?
  • What industry is Harmony Biosciences Holdings in?
  • What country is Harmony Biosciences Holdings based in?
  • When did Harmony Biosciences Holdings go public?
  • Is Harmony Biosciences Holdings in the S&P 500?
  • Is Harmony Biosciences Holdings in the NASDAQ 100?
  • Is Harmony Biosciences Holdings in the Dow Jones?
  • When was Harmony Biosciences Holdings's last earnings report?
  • When does Harmony Biosciences Holdings report earnings?
  • Should I buy Harmony Biosciences Holdings stock now?

What is the ticker symbol for Harmony Biosciences Holdings?

The ticker symbol for Harmony Biosciences Holdings is NASDAQ:HRMY

Does Harmony Biosciences Holdings pay dividends?

No, Harmony Biosciences Holdings does not pay dividends

What sector is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Healthcare sector

What industry is Harmony Biosciences Holdings in?

Harmony Biosciences Holdings is in the Biotechnology industry

What country is Harmony Biosciences Holdings based in?

Harmony Biosciences Holdings is headquartered in United States

When did Harmony Biosciences Holdings go public?

Harmony Biosciences Holdings's initial public offering (IPO) was on August 19, 2020

Is Harmony Biosciences Holdings in the S&P 500?

No, Harmony Biosciences Holdings is not included in the S&P 500 index

Is Harmony Biosciences Holdings in the NASDAQ 100?

No, Harmony Biosciences Holdings is not included in the NASDAQ 100 index

Is Harmony Biosciences Holdings in the Dow Jones?

No, Harmony Biosciences Holdings is not included in the Dow Jones index

When was Harmony Biosciences Holdings's last earnings report?

Harmony Biosciences Holdings's most recent earnings report was on Feb 25, 2025

When does Harmony Biosciences Holdings report earnings?

The next expected earnings date for Harmony Biosciences Holdings is Apr 30, 2025

Should I buy Harmony Biosciences Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page